{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T17:22:51Z","timestamp":1783963371561,"version":"3.55.0"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Lingguizhugan decoction is a traditional Chinese medicine prescription that has been used to improve non-alcoholic fatty liver disease and its progressive form, non-alcoholic steatohepatitis (NASH). However, the anti-NASH effects and underlying mechanisms of Lingguizhugan decoction remain unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Male Sprague-Dawley rats were fed a methionine- and choline-deficient (MCD) diet to induce NASH, and then given Lingguizhugan decoction orally for four weeks. NASH indexes were evaluated by histopathological analysis and biochemical parameters including serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), liver triglycerides (TG), <jats:italic>etc.<\/jats:italic> Fecal samples of rats were subjected to profile the changes of gut microbiota and metabolites using 16S rRNA sequencing and ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS). Bioinformatics was used to identify Lingguizhugan decoction reversed candidates, and Spearman\u2019s correlation analysis was performed to uncover the relationship among gut microbiota, fecal metabolites, and NASH indexes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Four-week Lingguizhugan decoction treatment ameliorated MCD diet-induced NASH features, as evidenced by improved hepatic steatosis and inflammation, as well as decreased serum AST and ALT levels. Besides, Lingguizhugan decoction partially restored the changes in gut microbial community composition in NASH rats. Meanwhile, the relative abundance of 26 genera was significantly changed in NASH rats, and 11 genera (such as <jats:italic>odoribacter, Ruminococcus_1<\/jats:italic>, <jats:italic>Ruminococcaceae_UCG-004, etc.<\/jats:italic>) were identified as significantly reversed by Lingguizhugan decoction. Additionally, a total of 99 metabolites were significantly altered in NASH rats, and 57 metabolites (such as TDCA, Glutamic acid, Isocaproic acid, <jats:italic>etc.<\/jats:italic>) enriched in different pathways were reversed by Lingguizhugan decoction. Furthermore, Spearman\u2019s correlation analyses revealed that most of the 57 metabolites were significantly correlated with 11 genera and NASH indexes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Lingguizhugan decoction may exert protective effects on NASH partially by modulating gut microbiota and correlated metabolites.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2023.1066053","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T05:16:51Z","timestamp":1674710211000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites"],"prefix":"10.3389","volume":"13","author":[{"given":"Mingzhe","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqi","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.3390\/nu11061356","article-title":"Glycine metabolism and its alterations in obesity and metabolic diseases","author":"Alves","year":"2019","journal-title":"Nutrients"},{"key":"B2","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives","author":"Arab","year":"2017","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.molmet.2016.06.003","article-title":"Non-alcoholic fatty liver and the gut microbiota","author":"Bashiardes","year":"2016","journal-title":"Mol. Metab."},{"key":"B4","doi-asserted-by":"publisher","first-page":"fj201800544","DOI":"10.1096\/fj.201800544","article-title":"The gut microbiota metabolite indole alleviates liver inflammation in mice","author":"Beaumont","year":"2018","journal-title":"FASEB J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1139\/m82-043","article-title":"Leucine dissimilation to isovaleric and isocaproic acids by cell suspensions of amino acid fermenting anaerobes: The stickland reaction revisited","author":"Britz","year":"1982","journal-title":"Can. J. Microbiol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155214","article-title":"Gut microbiota metabolites in NAFLD pathogenesis and therapeutic implications","volume":"21","author":"Chen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1080\/01480545.2019.1609493","article-title":"Evaluation of acute and subacute toxicity of sodium taurodeoxycholate in rats","author":"Choi","year":"2021","journal-title":"Drug Chem. Toxicol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mam.2017.04.004","article-title":"The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"56","author":"Chow","year":"2017","journal-title":"Mol. Aspects Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13020-021-00469-4","article-title":"Traditional Chinese medicine in nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives","author":"Dai","year":"2021","journal-title":"Chin. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s11684-021-0880-3","article-title":"Lingguizhugan decoction, a Chinese herbal formula, improves insulin resistance in overweight\/obese subjects with non-alcoholic fatty liver disease: A translational approach","author":"Dai","year":"2022","journal-title":"Front. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1530\/JOE-20-0018","article-title":"SCFAs alleviated steatosis and inflammation in mice with NASH induced by MCD","author":"Deng","year":"2020","journal-title":"J. Endocrinol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/nu13010144","article-title":"Role of gut microbiota and their metabolites on atherosclerosis, hypertension and human blood platelet function: A review","volume":"13","author":"Duttaroy","year":"2021","journal-title":"Nutrients"},{"key":"B14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/13543784.2020.1763302","article-title":"Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH)","author":"Fiorucci","year":"2020","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.2147\/DDDT.S315724","article-title":"Non-alcoholic steatohepatitis (NASH) - a review of a crowded clinical landscape, driven by a complex disease","volume":"15","author":"Fraile","year":"2021","journal-title":"Drug Des. Devel Ther."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200111R","article-title":"Intervention with isoleucine or valine corrects hyperinsulinemia and reduces intrahepatic diacylglycerols, liver steatosis, and inflammation in ldlr-\/-.Leiden mice with manifest obesity-associated NASH","author":"Gart","year":"2022","journal-title":"FASEB J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.metabol.2018.02.006","article-title":"Circulating bile acids in healthy adults respond differently to a dietary pattern characterized by whole grains, legumes and fruits and vegetables compared to a diet high in refined grains and added sugars: A randomized, controlled, crossover feeding study","volume":"83","author":"Ginos","year":"2018","journal-title":"Metabolism"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1007\/s00253-022-11771-y","article-title":"Comparative analysis of microbial communities from different full-scale haloalkaline biodesulfurization systems","author":"Gupta","year":"2022","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153544","article-title":"Si Miao formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota","volume":"85","author":"Han","year":"2021","journal-title":"Phytomedicine"},{"key":"B20","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1038\/s41467-021-25701-5","article-title":"A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes","author":"Harrison","year":"2021","journal-title":"Nat. Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12876-017-0652-3","article-title":"Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: An open-label, single-arm, multicenter, pilot study","author":"Honda","year":"2017","journal-title":"BMC Gastroenterol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/nu14142945","article-title":"Specific strains of faecalibacterium prausnitzii ameliorate nonalcoholic fatty liver disease in mice in association with gut microbiota regulation","volume":"14","author":"Hu","year":"2022","journal-title":"Nutrients"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105444","article-title":"Baicalin and the liver-gut system: Pharmacological bases explaining its therapeutic effects","volume":"165","author":"Hu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/4704771","article-title":"Dietary valine ameliorated gut health and accelerated the development of nonalcoholic fatty liver disease of laying hens","volume":"2021","author":"Jian","year":"2021","journal-title":"Oxid. Med. Cell Longev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","author":"Jiao","year":"2018","journal-title":"Gut"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.634780","article-title":"Impact of gut microbiota and microbiota-related metabolites on hyperlipidemia","volume":"11","author":"Jia","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1124\/mol.113.091165","article-title":"Microbiome-derived tryptophan metabolites and their aryl hydrocarbon receptor-dependent agonist and antagonist activities","author":"Jin","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/nu11081712","article-title":"Gut microbiota-derived components and metabolites in the progression of non-alcoholic fatty liver disease (NAFLD)","volume":"11","author":"Ji","year":"2019","journal-title":"Nutrients"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/ncomms2852","article-title":"The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43","volume":"4","author":"Kimura","year":"2013","journal-title":"Nat. Commun."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4982","DOI":"10.1038\/s41467-020-18754-5","article-title":"Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3892\/etm.2013.1434","article-title":"Effects of glutamine on oxidative stress and nuclear factor-kappaB expression in the livers of rats with nonalcoholic fatty liver disease","author":"Lin","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/429738","article-title":"Chinese Medicine formula lingguizhugan decoction improves beta-oxidation and metabolism of fatty acid in high-fat-diet-induced rat model of fatty liver disease","volume":"2013","author":"Liu","year":"2013","journal-title":"Evid Based Complement Alternat Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.2174\/1381612823666170918120643","article-title":"Natural active compounds from plant food and Chinese herbal medicine for nonalcoholic fatty liver disease","author":"Liu","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111587","article-title":"Salvia-nelumbinis naturalis extract protects mice against MCD diet-induced steatohepatitis via activation of colonic FXR-FGF15 pathway","volume":"139","author":"Li","year":"2021","journal-title":"BioMed. Pharmacother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3:317","DOI":"10.1111\/liv.13031","article-title":"The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment","volume":"36","author":"Margini","year":"2016","journal-title":"Liver Int."},{"key":"B38","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3390\/antiox9100909","article-title":"Mitochondrial glutathione: Recent insights and role in disease","author":"Mari","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/nature08530","article-title":"Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43","author":"Maslowski","year":"2009","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1177\/2050640618804444","article-title":"Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease","author":"Rau","year":"2018","journal-title":"United Eur. Gastroenterol. J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2741\/4892","article-title":"Current treatment paradigms and emerging therapies for NAFLD\/NASH","author":"Raza","year":"2021","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0007114514000440","article-title":"Effect of tryptophan supplementation on diet-induced non-alcoholic fatty liver disease in mice","author":"Ritze","year":"2014","journal-title":"Br. J. Nutr."},{"key":"B43","doi-asserted-by":"publisher","first-page":"eaaz2841","DOI":"10.1126\/scitranslmed.aaz2841","article-title":"Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome","author":"Rom","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1021\/acs.jafc.0c07467","article-title":"Gut microbiota and its metabolite deoxycholic acid contribute to sucralose consumption-induced nonalcoholic fatty liver disease","author":"Shi","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32568","article-title":"Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD","author":"Smirnova","year":"2022","journal-title":"Hepatology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1093\/ibd\/izy103","article-title":"Tryptophan metabolism through the kynurenine pathway is associated with endoscopic inflammation in ulcerative colitis","author":"Sofia","year":"2018","journal-title":"Inflammation Bowel Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/MCO.0000000000000706","article-title":"Protein and amino acids in nonalcoholic fatty liver disease","author":"Trico","year":"2021","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.cgh.2017.04.016","article-title":"A randomized trial of silymarin for the treatment of nonalcoholic steatohepatitis","author":"Wah Kheong","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/hepr.12788","article-title":"Emodin alleviates hepatic steatosis by inhibiting sterol regulatory element binding protein 1 activity by way of the calcium\/calmodulin-dependent kinase kinase-AMP-activated protein kinase-mechanistic target of rapamycin-p70 ribosomal S6 kinase signaling pathway","author":"Wang","year":"2017","journal-title":"Hepatol. Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e9302","DOI":"10.1002\/imt2.61","article-title":"Targeting keystone species helps restore the dysbiosis of butyrate-producing bacteria in nonalcoholic fatty liver disease","author":"Wu","year":"2022","journal-title":"iMeta"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103290","article-title":"Conjugated secondary 12alpha-hydroxylated bile acids promote liver fibrogenesis","volume":"66","author":"Xie","year":"2021","journal-title":"EBioMedicine"},{"key":"B52","doi-asserted-by":"publisher","first-page":"5709","DOI":"10.1021\/acs.analchem.0c04686","article-title":"A metabolite array technology for precision medicine","author":"Xie","year":"2021","journal-title":"Anal. Chem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1186\/s13063-020-04362-7","article-title":"Traditional Chinese medicine lingguizhugan decoction treating non-alcoholic fatty liver disease with spleen-yang deficiency pattern: Study protocol for a multicenter randomized controlled trial","author":"Xu","year":"2020","journal-title":"Trials"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.dld.2021.02.013","article-title":"Microbiome, fibrosis and tumor networks in a non-alcoholic steatohepatitis model of a choline-deficient high-fat diet using diethylnitrosamine","author":"Yamamoto","year":"2021","journal-title":"Dig Liver Dis."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4801695","article-title":"Intervention of shugan xiaozhi decoction on nonalcoholic fatty liver disease via mediating gut-liver axis","volume":"2022","author":"Yang","year":"2022","journal-title":"BioMed. Res. Int."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.2147\/DDDT.S243893","article-title":"Radix polygoni multiflori and its main component emodin attenuate non-alcoholic fatty liver disease in zebrafish by regulation of AMPK signaling pathway","volume":"14","author":"Yu","year":"2020","journal-title":"Drug design Dev. Ther."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s11655-014-1999-8","article-title":"Effect of alternate-day fasting therapy combined with linggui zhugan decoction () on hepatic oxidative stress in hyperlipidemic rat","author":"Zhang","year":"2015","journal-title":"Chin. J. Integr. Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.molcel.2022.01.021","article-title":"Amelioration of hepatic steatosis by dietary essential amino acid-induced ubiquitination","author":"Zhang","year":"2022","journal-title":"Mol. Cell"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.biopha.2018.03.158","article-title":"Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats","volume":"102","author":"Zhang","year":"2018","journal-title":"BioMed. Pharmacother."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110076","article-title":"Gegen qinlian decoction abates nonalcoholic steatohepatitis associated liver injuries via anti-oxidative stress and anti-inflammatory response involved inhibition of toll-like receptor 4 signaling pathways","volume":"126","author":"Zhang","year":"2020","journal-title":"BioMed. Pharmacother."},{"key":"B61","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.biopha.2017.03.003","article-title":"Berberine inhibits palmitate-induced NLRP3 inflammasome activation by triggering autophagy in macrophages: A new mechanism linking berberine to insulin resistance improvement","volume":"89","author":"Zhou","year":"2017","journal-title":"BioMed. Pharmacother."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2022.109041","article-title":"Indole supplementation ameliorates MCD-induced NASH in mice","volume":"107","author":"Zhu","year":"2022","journal-title":"J. Nutr. Biochem."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1066053\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T05:16:55Z","timestamp":1674710215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1066053\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,26]]},"references-count":62,"alternative-id":["10.3389\/fcimb.2023.1066053"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2023.1066053","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,26]]},"article-number":"1066053"}}